Table 1.
Baseline participant characteristics
| BAL | SKEW | P | |
|---|---|---|---|
| Age, yr | 65 ± 3 | 66 ± 4 | 0.35 |
| Height, m | 1.76 ± 0.06 | 1.74 ± 0.05 | 0.46 |
| Body mass, kg | 97.2 ± 14.0 | 95.8 ± 13.9 | 0.82 |
| Body mass index, kg/m2 | 31.4 ± 4.8 | 31.4 ± 4.6 | 0.94 |
| Fat mass, kg | 29.1 ± 8.6 | 28.8 ± 9.0 | 0.93 |
| Lean body mass, kg | 66.8 ± 7.1 | 66.0 ± 5.1 | 0.77 |
| ASMM, kg | 28.2 ± 3.3 | 27.7 ± 2.7 | 0.75 |
| Fasting blood glucose, mM | 5.7 ± 0.5 | 5.6 ± 0.5 | 0.76 |
| HOMA | 3.8 ± 2.9 | 2.1 ± 1.1 | 0.21 |
| HbA1c, % | 5.0 ± 0.0 | 5.2 ± 0.2 | 0.48 |
| Steps per day | 8,535 ± 3,941 | 6,880 ± 3,899 | 0.49 |
Values are means ± SD; n = 10 participants/group. BAL, balanced; SKEW, skewed; ASMM, appendicular skeletal muscle mass, HOMA; homeostatic model assessment of insulin resistance.